Costs of integrated mass drug administration for neglected tropical diseases in Haiti

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 5, 2011, Pages 826-833

  Goldman, Ann S ^a,e   Brady, Molly A ^b,e   Direny, Abdel ^c,e   Desir, Luccene ^d,e   Oscard, Roland ^e,f   Vely, Jean Francois ^d   Linehan, Mary ^e,g   Baker, Margaret ^e,h  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c Hôpital Saint Francois de Sales   (Haïti)

^d Hôpital Ste Croix ^*

^e UNIVERSITY OF NOTRE DAME   (United States)

^f Ministère de la Santé Publique et de la Population   (Haïti)

^g US Agy for Intl Development   (Indonesia)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ARTICLE; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DRUG COST; EXPERIENCE; FILARIASIS; HAITI; HEALTH SURVEY; HELMINTHIASIS; HUMAN; RETROSPECTIVE STUDY; TROPICAL DISEASE;

ALBENDAZOLE; ANTHELMINTICS; COSTS AND COST ANALYSIS; DIETHYLCARBAMAZINE; DRUG THERAPY; ELEPHANTIASIS, FILARIAL; HAITI; HELMINTHIASIS; HUMANS; NEGLECTED DISEASES; PREVALENCE;

EID: 81155131396     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0635     Document Type: Article

References (11)

1. Conteh L, Engels T, Molyneux DH, 2010. Socioeconomic aspects of neglected tropical diseases. Lancet 375: 239-247.
2. UNICEF, 2010. At a Glance: Haiti. Available at: http://www.unicef .org/infobycountry/haiti-statistics.html?q=printme.
3. Ministere de la Sante Publique et de la Population, 2010. Plan Interimaire du Secture Sante: Avril 2010-Septembre 2011. Available at: http://www.mspp.gouv.ht/site/download/plan-interimaire.pdf.
4. Beau de Rochars MV, Milord MD, St Jean Y, Désormeaux AM, Dorvil JJ, Lafontant JG, Addiss DG, Streit TG, 2004. Geographic distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg 71: 598-601. (Pubitemid 39601158)
5. World Health Organization, 2006. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelmanthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers. Geneva: World Health Organization.
6. de Rochars MB, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ, 2004. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am J Trop Med Hyg 71: 466-470. (Pubitemid 39458340)
7. Goldman AS, Guisinger VH, Aikins M, Amarillo ML, Belizario VY, Garshong B, Gyapong J, Kabali C, Kamal HA, Kanjilal S, Kyelem D, Lizardo J, Maleceda M, Mubyazi G, Nitièma PA, Ramzy RM, Streit TG, Wallace A, Brady MA, Rheingans R, Ottesen EA, Haddix AC, 2007. National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl Trop Dis 1: e67.
8. de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ, 2005. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg 73: 888-894. (Pubitemid 41688464)
9. A Generic Protocol for Analyzing the Costs of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis, 2003. Decatur, GA : Lymphatic Filariasis Support Center.
10. McFarland DA, Hooper PJ, 2008. Protocol for Data Collection of Costs in NTD Integration Projects. Atlanta, GA: Rollins School of Public Health of Emory University.
11. The World Bank, 2011. World Development Indicators: Inflation, GDP Deflator (Annual %). Available at : http://data.world bank.org/indicator/NY.GDP. DEFL.KD.ZG. Accessed May 20, 2011.